2014
DOI: 10.1016/j.mce.2013.11.010
|View full text |Cite
|
Sign up to set email alerts
|

Real-time trafficking and signaling of the glucagon-like peptide-1 receptor

Abstract: The glucagon-like peptide-1 incretin receptor (GLP-1R) of family B G protein-coupled receptors (GPCRs) is a major drug target in type-2-diabetes due to its regulatory effect on post-prandial blood-glucose levels. The mechanism(s) controlling GLP-1R mediated signaling are far from fully understood. A fundamental mechanism controlling the signaling capacity of GPCRs is the post-endocytic trafficking of receptors between recycling and degradative fates. Here, we combined microscopy with novel real-time assays to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
140
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 133 publications
(149 citation statements)
references
References 22 publications
9
140
0
Order By: Relevance
“…These changes might account for the finding indicating that, after 6 days, the wounds received Exe4 were more healed than those treated with NT, exendin-4(9-39) but also with Exendin-4(9-39) þExe4. Furthermore, we found, in line with that already described by Ishibashi et al (2011), myofibroblasts positive for GLP-1R immunostaining both at the plasma membrane and intracellular (Widmann et al, 1995;Roed et al, 2013). In addition, activation of the mitogenic ERK1/2, was described as part of the intracellular cascade activated by GLP-1R (Favaro et al, 2012).…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…These changes might account for the finding indicating that, after 6 days, the wounds received Exe4 were more healed than those treated with NT, exendin-4(9-39) but also with Exendin-4(9-39) þExe4. Furthermore, we found, in line with that already described by Ishibashi et al (2011), myofibroblasts positive for GLP-1R immunostaining both at the plasma membrane and intracellular (Widmann et al, 1995;Roed et al, 2013). In addition, activation of the mitogenic ERK1/2, was described as part of the intracellular cascade activated by GLP-1R (Favaro et al, 2012).…”
Section: Discussionsupporting
confidence: 90%
“…Exe4 activates GLP-1 receptor (GLP-1R) thus mimicking most of GLP-1 effects including the ability to induce receptor phosphorylation and internalization (Roed et al, 2013), two mechanisms ensuring a continuous recycling from intracellular stores towards the plasma membrane (Widmann et al, 1995). Since the insulinotropic activity of GLP-1 was found dysregulated in diabetic patients (Meier and Nauck, 2010), a synthetic version of Exe4, exenatide, became recently part of an innovative anti-diabetic therapy (incretin analogues).…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, in our experiments, 10 pmol/L GLP-1 and exendin-4 effectively enhanced the GABA-activated current response with a similar time constant of activation (2 min), an apparent synchrony with the lifetime of GLP-1 in plasma. Recently, Roed et al (23) determined the half-maximal concentration for activation (EC 50 ) of the GLP-1 receptor expressed in human embryonic kidney cells to be 9.8 6 1.0 pmol/L. They further determined the EC 50 of GLP-1 for inducing GLP-1 receptors internalization to be 12 6 5 nmol/L and showed that maximal internalization level occurred with supersaturating concentrations (1 mmol/L) within 15-20 min.…”
Section: Discussionmentioning
confidence: 99%
“…Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23). Since GLP-1 once bound to the GLP-1 receptor starts intracellular cascades leading to activation of various proteins, it is essential to apply the inhibitor first and only then coapply GLP-1 together with the inhibitor in order to prevent GLP-1 effects on neuronal function such as modulation of the GABA signaling.…”
Section: Glp-1 Receptor Antagonist Exendin (9-39) Inhibits Glp-1 Modumentioning
confidence: 99%
See 1 more Smart Citation